Compounds and methods to enhance rAAV transduction

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S018700, C514S019300, C514S450000, C540S450000

Reexamination Certificate

active

07122335

ABSTRACT:
Agents and methods to alter rAAV transduction, including agents and methods to enhance rAAV transduction, are provided. For instance, the invention provides methods to identify agents that enhance AAV transduction after viral binding to the cell membrane and before second strand synthesis.

REFERENCES:
patent: 5604090 (1997-02-01), Alexander et al.
patent: 5691176 (1997-11-01), Lebkowski et al.
patent: 5801030 (1998-09-01), McVey et al.
patent: 5831068 (1998-11-01), Nair et al.
patent: 5834182 (1998-11-01), Alexander et al.
patent: 5843742 (1998-12-01), Natsoulis et al.
patent: 6083702 (2000-07-01), Mitchell et al.
patent: 6156303 (2000-12-01), Russell et al.
patent: 6200560 (2001-03-01), Couto et al.
patent: 6221349 (2001-04-01), Couto et al.
patent: 6287569 (2001-09-01), Kipps et al.
patent: 6436392 (2002-08-01), Engelhardt et al.
patent: 6544786 (2003-04-01), Xiao et al.
patent: 6897045 (2005-05-01), Engelhardt et al.
patent: 2002/0076754 (2002-06-01), Sun et al.
patent: 2002/0131956 (2002-09-01), Walsh et al.
patent: 2002/0197237 (2002-12-01), Engelhardt et al.
patent: 2003/0103939 (2003-06-01), Engelhardt et al.
patent: 2005/0037497 (2005-02-01), Engelhardt et al.
patent: 2005/0095225 (2005-05-01), Engelhardt et al.
patent: 2302627 (2001-09-01), None
patent: 1153612 (2001-11-01), None
patent: WO-94/13788 (1992-12-01), None
patent: WO-95/07351 (1993-09-01), None
patent: WO-95/15384 (1994-11-01), None
patent: WO-97/22250 (1997-06-01), None
patent: WO-98/09657 (1998-03-01), None
patent: WO-99/60146 (1998-05-01), None
patent: WO 98/24479 (1998-06-01), None
patent: WO-98/53839 (1998-12-01), None
patent: WO-00/47220 (2000-02-01), None
patent: WO-01/83692 (2001-11-01), None
patent: WO-02/087306 (2002-11-01), None
patent: WO-2004/090145 (2004-10-01), None
Ferrari et al. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol. May 1996;70(5):3227-34.
Alberts et al. (1994) Molecular Biology of the Cell, third edition, Garland Publishing, Inc. New York, pp. 618-626.
Kessler et al., Sodium butyrate enhances the efficiency of viral transduction in adult ventricular cardiomyocytes by adeno-associated viral vectors, 1995, CIRCULATION, vol. 92.
Arcamone, F M., “From the Pigments of the Actinomycetes to Third Generation Antitumor Anthracyclines”,Biochimie(Paris), 80(3), (Mar. 1998),201-206.
Elliott, P J., et al., “Recent Advances in Understanding Proteasome Function”,Current Opinion in Drug Discovery and Development, 5 (2), ISSN: 1367-6733,(1999),484-490.
Kiyomiya, K.-I., et al., “The Role of the Proteasome in Apoptosis Induced by Anthracycline Anticancer Agents”,International Journal of Oncology, 20 (6), (Jun. 2002), 1205-1209.
Spindler, B. , et al., “Characterization of Early Aldosterone-induced RNAs identified in A6 Kidney Epithelia”,Pfluegers Archiv, vol. 434, Springer Verlag, Berlin, DE, (1997), 323-331.
Yan, Z., et al., “Distinct Classes of Proteasome-Modulating Agents Cooperatively Augment Recombinant Adeno-Associated Virus Type 2 and Type 5-Mediated Transduction from the Apical Surfaces of Human Airway Epithelia”,Journal of Virology, 78, (Mar. 2004),2863-2874.
Zentner, M. D., “The Amiloride-Sensitive Epithelial Sodium Channel α-Subunit is Transcriptionally Down-Regulated in Rat Parotid Cells by the Extracellular Signal-Regulated Protein Kinase Pathway”,The Journal of Biological Chemistry, 273(46), (1998),30770-30776.
Bank, U., “Review: Peptidases and Peptidase Inhibitors in the Pathogenesis of Diseases”,Cellular Peptidases in Immune Functions and Diseases 2, (Edited by Jurgen Langner, et al., Kluwer Academic / Plenum Publishers),(2000),349-378.
Brötz, H., “The Lantibiotic Mersacidin Inhibits Peptidoglycan Biosynthesis and the Level of Transglycosylation”,Eur. J. Biochem., 246(1), (1997),193-199.
Douar, A.-M., et al., “Intracellular Trafficking of Adeno-Associated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome Degration”,Journal of Virology, 75(4), (2001), 1824-1833.
Duan, D., et al., “A New Dual-Vector Approach to Enhance Recombinant Adeno-Associated Virus-Mediated Gene Expression Through Intermolecular cis Activation”,Nature Medicine, 6(5), (2000), 595-598.
Duan, D. , et al., “Enhancement of Muscle Gene Delivery With Pseudotyped Adeno-Associated Virus Type 5 Correlates With Myoblast Differentiation”,Journal of Virology, 75(16), (2001), 7662-7671.
Flotte, T. R., et al., “Adeno-Associated Virus Vector Gene Expression Occurs in Nondividing Cells in the Absence of Vector DNA Integration”,American Journal of Respiratory Cell and Molecular Biology, 11, (1994), 517-521.
Hansen, J. , et al., “Adeno-Associated Virus Type 2-Mediated Gene Transfer: Altered Endocytic Processing Enhances Transduction Efficiency in Murine Fibroblasts”,Journal of Virology, 75(9), (2001), 4080-4090.
Hansen, J. , et al., “Impaired Intracellular Trafficking of Adeno-Associated Virus Type 2 Vectors Limits Efficient Transduction of Murine Fibroblasts”,Journal of Virology, 74(2), (2000),992-996.
Parker, J. S., et al., “Cellular Uptake and Infection by Canine Parvovirus Involves Rapid Dynamin-Regulated Clathrin-Mediated Endocytosis, Followed by Slower Intracellular Trafficking”,Journal of Virology, 74(4), (2000),1919-1930.
Sanlioglu, S. , et al., “Endocytosis and Nuclear Traffickling of Adeno-Associated Virus Type 2 Are Controlled by Rac1 and Phosphatidylinositol-3 Kinase Activation”,Journal of Virology, 74(19), (2000),9184-9196.
Sanlioglu, S., et al., “Loss of ATM Function Enhances Recombinant Adeno-Associated Virus Transduction and Integration Through Pathways Similar to UV Irradiation”,Virology, 268, (2000),68-78.
Sanlioglu, S., et al., “Rate Limiting Steps of AAV Transduction and Implications for Human Gene Therapy”,Current Gene Therapy, 1, (2001),137-147.
Sanlioglu, S., et al., “Two Independent Molecular Pathways for Recombinant Adeno-Associated Virus Genome Conversion Occur After UV-C and E4orf6 Augmentation of Transduction”,Human Gene Therapy, 10(4), (1999),591-602.
Sasaki, T., et al., “Inhibitory Effect of di- and Tripeptidyl Aldehydes on Calpains and Cathepsins”,Journal of Enzyme Inhibition, 3(3), (1990),195-201.
Staub, O., “Chapter 5 Regulation of ENaC by Interacting Proteins and by Ubiquitination”,Current Topics in Membranes, 47—Amiloride-Sensitive Sodium Channels—Physiology and Functional Diversity, Edited by Dale J. Benos, Academic Press, Publisher,(1999),65-87.
Staub, O., “Regulation of Stability and Functional of the Epithelial Na+Channel (ENaC) by Ubiquitination”,The EMBO Journal, 16(21), (1997),6325-6336.
Stokes, J. B., “Regulation of rENac mRNA by Dietary NaCl and Steroids: Organ, Tissue, and Steroid Heterogeneity”,American Journal of Physiology, Cell Physiology, 274, (1998),C1699-C1707.
Berns, K. I., et al., “Biology of Adeno-associated Virus”,In: Current Topics in Microbiology and Immunology,218, Springer-Verlag, Berlin: R.W. Compans, et al., (Eds.),(1996),pp. 1-23.
Berns, K. I., “Parvovirus Replication”,Microbiological Reviews, 54 (3), (Sep. 1990),pp. 316-329.
Duan, Dongsheng , et al., “Circular intermediates of recombinant adeno-associated virus having defined structural characteristics responsible for long-term episomal persistence in muscle tissue”,J. of Virology, 72 (11), (Nov. 1998),pp. 8568-8577.
Duan, Dongsheng , et al., “Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus”,Journal of Clinical Investigation, vol. 105, No. 11, (Jun. 2000),1573-1587.
Duan, Dongsheng , et al., “Structural Analysis of adeno-associated virus transduction circular intermediates”,Virology, 261 (1), (Aug. 1999),pp. 8-14.
Duan, Dongsheng , et al., “Structura

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compounds and methods to enhance rAAV transduction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and methods to enhance rAAV transduction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods to enhance rAAV transduction will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3660047

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.